Lanell M. Peterson

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients

Janet S. Rasey, Wui-Jin Koh, Margaret L. Evans et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 563 citations

Positron Emission Tomography, Engineering, Oncologic Imaging +9

Hypoxia and Glucose Metabolism in Malignant Tumors

Joseph G. Rajendran, David A. Mankoff, Finbarr O’Sullivan et al. · Clinical Cancer Research · 2004 · 390 citations · Full text

Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast Cancer

Hannah M. Linden, S. A. Stekhova, Jeanne M. Link et al. · Journal of Clinical Oncology · 2006 · 390 citations

Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer

Joseph G. Rajendran, David A. Schwartz, Janet OʼSullivan et al. · Clinical Cancer Research · 2006 · 349 citations · Full text

In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors.

Hubert Vesselle, John R. Grierson, Mark Muzi et al. · PubMed · 2002 · 299 citations